The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions
- PMID: 21190638
- PMCID: PMC3202750
- DOI: 10.4088/JCP.09m05663gry
The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Abstract
Objective: To examine the prevalence of chronic major depressive disorder (CMDD) and dysthymic disorder, their sociodemographic correlates, patterns of 12-month and lifetime psychiatric comorbidity, lifetime risk factors, psychosocial functioning, and mental health service utilization.
Method: Face-to-face interviews were conducted in the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (n = 43,093).
Results: The 12-month and lifetime prevalences were greater for CMDD (1.5% and 3.1%, respectively) than for dysthymic disorder (0.5% and 0.9%, respectively). Individuals with CMDD and dysthymic disorder shared most sociodemographic correlates and lifetime risk factors for major depressive disorder. Individuals with CMDD and dysthymic disorder had almost identically high rates of Axis I and Axis II comorbid disorders. However, individuals with CMDD received higher rates of all treatment modalities than individuals with dysthymic disorder.
Conclusions: Individuals with CMDD and dysthymic disorder share many sociodemographic correlates, comorbidity patterns, risk factors, and course. Individuals with chronic depressive disorders, especially those with dysthymic disorder, continue to face substantial unmet treatment needs.
© Copyright 2010 Physicians Postgraduate Press, Inc.
References
-
- Hasin DS, Goodwin RD, Stinson FS, et al. The epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097–1106. - PubMed
-
- Murray C, Lopez AD. Alternative visions of the future: projecting mortality and disability, 1990–2020. Cambridge: Harvard University Press; 1996.
-
- World Health Organization. The world health report 2001 mental health: new understanding, new hope. Geneva: World Health Organization; 2001. p. 178.
-
- Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49(10):809–816. - PubMed
-
- Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462–1470. - PubMed
Publication types
MeSH terms
Grants and funding
- MH076051/MH/NIMH NIH HHS/United States
- K02 DA023200/DA/NIDA NIH HHS/United States
- R01 MH076051/MH/NIMH NIH HHS/United States
- DA019606/DA/NIDA NIH HHS/United States
- R01 DA020783/DA/NIDA NIH HHS/United States
- R01 DA019606/DA/NIDA NIH HHS/United States
- AA014223-03/AA/NIAAA NIH HHS/United States
- DA023200/DA/NIDA NIH HHS/United States
- DA023973/DA/NIDA NIH HHS/United States
- K05 AA014223/AA/NIAAA NIH HHS/United States
- DA020783/DA/NIDA NIH HHS/United States
- R01 DA023973/DA/NIDA NIH HHS/United States
- Z01 AA000449/ImNIH/Intramural NIH HHS/United States
- MH079078/MH/NIMH NIH HHS/United States
- R01 MH079078/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
